Pi15 Inhibitors
Pi15 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the protein Pi15, which is a member of the serpin (serine protease inhibitor) family. Pi15 plays a significant role in regulating various biological processes by modulating the activity of serine proteases, enzymes that are critical for numerous physiological functions, including blood coagulation, immune responses, and tissue remodeling. By inhibiting Pi15, these compounds can disrupt its function in these pathways, leading to altered protease activity and influencing various biological outcomes.
The study of Pi15 inhibitors is essential for understanding the complex mechanisms of protease regulation and its implications in biological systems. These inhibitors provide valuable tools for elucidating the specific roles of Pi15 in cellular functions and its interactions with other proteins in the serpin family. Research into Pi15 inhibitors can reveal insights into the balance between protease activity and inhibition, which is crucial for maintaining homeostasis within the body. Additionally, exploring the effects of Pi15 inhibition can enhance our understanding of proteolytic processes and their impact on physiological conditions such as inflammation, wound healing, and tissue repair. The characterization of this class of inhibitors thus contributes to a broader comprehension of the regulatory networks involving serine proteases and their inhibitors in biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a potent proteasome inhibitor, which may potentially impact the degradation of PI15, leading to an increase in its expression levels. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin inhibits the proteasome, potentially impacting the degradation of PI15 and leading to an increase in its expression levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, potentially impacting the degradation of PI15, leading to an increase in its expression levels. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin inhibits the proteasome, potentially impacting the degradation of PI15 and leading to an increase in its expression levels. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PI15 expression, leading to altered gene expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PI15 expression, leading to altered gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PI15 expression, leading to altered gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PI15 expression, leading to altered gene expression. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PI15 expression, leading to altered gene expression. | ||||||